ESSA Pharma Langfristige Verbindlichkeiten 2011-2026 | EPIX

Langfristige Verbindlichkeiten Jährlich ESSA Pharma

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	127 K	18.2 K	3.52 M	6.1 M	-	-	-	-	-	-

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
6.1 M	18.2 K	2.44 M

Langfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name	Langfristige Verbindlichkeiten	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Amgen AMGN	37.2 B	$ 349.36	2.75 %	$ 188 B	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Amneal Pharmaceuticals AMRX	2.79 B	$ 12.67	2.82 %	$ 3.97 B	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Applied Therapeutics APLT	797 K	-	-	$ 8.42 M	USA
argenx SE ARGX	226 M	$ 784.45	2.48 %	$ 25 B	Niderland
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
Arcutis Biotherapeutics ARQT	167 M	$ 24.45	5.07 %	$ 3.11 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	30.8 B	-	-	$ 96.9 B	Britain
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Autolus Therapeutics plc AUTL	50.6 M	$ 1.47	8.17 %	$ 391 M	Britain
BeiGene, Ltd. BGNE	2 B	-	0.49 %	$ 251 B	Cayman-islands
Alterity Therapeutics Limited ATHE	73.6 K	$ 3.83	1.86 %	$ 9.21 B	Australia
BioNTech SE BNTX	341 M	$ 91.3	1.87 %	$ 27.2 B	Germany
CymaBay Therapeutics CBAY	1.26 M	-	-	$ 3.45 B	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Aytu BioScience AYTU	42.1 M	$ 2.72	5.84 %	$ 17.1 M	USA
Avid Bioservices CDMO	21.2 M	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	942 K	-	-	$ 1.41 B	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Cabaletta Bio CABA	43.9 M	$ 3.07	-	$ 308 M	USA
Can-Fite BioPharma Ltd. CANF	1.63 M	$ 3.08	1.65 %	$ 6.7 B	Israel
Checkpoint Therapeutics CKPT	2.47 M	-	-	$ 169 M	USA
Cerus Corporation CERS	58.1 M	$ 1.93	4.89 %	$ 368 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Concert Pharmaceuticals CNCE	17.9 M	-	-	$ 401 M	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
CTI BioPharma Corp. CTIC	1.17 M	-	-	$ 1.2 B	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada
Cyclacel Pharmaceuticals CYCCP	1.06 M	-	-4.36 %	$ 27 M	USA
Cellectar Biosciences CLRB	422 K	$ 2.82	2.55 %	$ 7.36 M	USA
Deciphera Pharmaceuticals DCPH	15.9 M	-	-	$ 2.18 B	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Dynavax Technologies Corporation DVAX	218 M	-	-	$ 2.02 B	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Cyclerion Therapeutics CYCN	70.5 M	$ 3.47	-0.29 %	$ 8.74 M	USA